Lupin schedules Q2 earnings call for Lupin stock on November 4
Published on 10/20/2026 at 03:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming report and operating figures
- Lupin scheduled its earnings call for November 4, 2026, at 18:00 IST.
- Revenue increased 32.04 percent in the first quarter of fiscal 2027.
- Lupin's market capitalization stood at INR 886.8 billion on October 19, 2026.
Lupin (ISIN INE326A01037) scheduled its second-quarter fiscal 2027 earnings call for November 4, 2026, at 18:00 IST, while its first-quarter revenue had grown 32.04 percent year over year to INR 82.77 billion. StockFin reported the call schedule on October 19, 2026.
Three recent company events
Sharpely lists three dated developments: Lupin received tentative U.S. Food and Drug Administration approval for apixaban oral suspension on September 28, 2026; it launched Formoflo-G MDI on October 6, 2026; and it scheduled the November 4 earnings call on October 19, 2026.
The chronology points to a portfolio that is still being expanded through regulatory approvals and product launches. The next call will give investors a fresh update on the quarter ended September 30, 2026, rather than another historical earnings snapshot.
What does the next report mean?
The operating baseline is substantial. KoalaGains reported revenue of INR 82.77 billion and an operating margin of 25.35 percent for the first quarter of fiscal 2027. Net income was INR 14.15 billion in that period, giving the November update three measurable benchmarks: growth, margin and profit.
For comparison, Lupin generated INR 279.58 billion of revenue in fiscal 2026, up 23.12 percent from the previous fiscal year, according to the same analysis. The latest quarterly growth rate therefore exceeded the full-year rate by 8.92 percentage points, although the figures cover different reporting periods.
November dates set
Lupin's board is scheduled to review unaudited results for the quarter and half-year ended September 30 on November 3, 2026, while the earnings call follows on November 4, 2026. StockFin reported the board date, and its separate filing page gives the call date and time.
Market value and trading context
Lupin's market capitalization stood at INR 886.8 billion on October 19, 2026. Its NSE quotation was INR 1,939.20 at 3:29 p.m. IST on that date, against a 52-week range of INR 1,900.00 to INR 2,529.50. The next company update will test whether the first-quarter revenue pace can carry into the September quarter.
Lupin stock key facts
- Company: Lupin Limited
- ISIN: INE326A01037
- Ticker: LUPIN
- Primary exchange: NSE
- Market capitalization: INR 886.8 billion (as of October 19, 2026)
- 52-week range: INR 1,900.00-2,529.50 (as of October 19, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
Market context: Market report BSE Sensex.
